San Diego, CA, United States of America

Rachel Soloff Nugent

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 44(Granted Patents)


Location History:

  • La Jolla, CA (US) (2013)
  • San Diego, CA (US) (2012 - 2021)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Rachel Soloff Nugent: Innovator in Antibody Development

Introduction

Rachel Soloff Nugent is a prominent inventor based in San Diego, California. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of seven patents to her name, her work has advanced the understanding and application of antibody technology.

Latest Patents

Among her latest patents is the invention of a human monoclonal antibody targeting human CD134 (OX40). This invention provides antibodies that specifically bind to OX40, referred to as OX40 antibodies, anti-OX40, or anti-OX40 antibodies. The antibodies include mammalian, humanized, and chimeric variants, which are useful in various methods, including treatment, screening, and detection. Another notable patent involves FN14 antibodies, which are designed to bind to Fn14, acting as antagonists and non-agonists of Fn14.

Career Highlights

Rachel has worked with notable companies in the biotechnology sector, including Kyowa Hakko Kirin Co., Limited and Kyowa Kirin Co., Ltd. Her expertise in antibody development has positioned her as a key player in the industry, contributing to innovative solutions in therapeutic applications.

Collaborations

Throughout her career, Rachel has collaborated with esteemed colleagues such as Shinichiro Kato and Hitoshi Yoshida. These partnerships have further enhanced her research and development efforts in the field of monoclonal antibodies.

Conclusion

Rachel Soloff Nugent's contributions to antibody technology exemplify her innovative spirit and dedication to advancing medical science. Her patents and collaborations reflect her significant impact on the biotechnology industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…